Consistently, in vivo limiting dilution assays showed that as low as 500 PTPRZ1+ glioma cells were sufficient to initiate the intracranial tumour growth, whereas a minimum of 5 × 103 PTPRZ1− glioma cells were required for tumour formation (Fig. 6d). This evidence concerns the gene PTPRZ1 and central nervous system cancer.